Financials in USD. Standardized financial statements.
A compact view of how BioCorRx Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $797,244 | $7,665 | $89,160 | $213,841 | $48,272 | $122,621 | $240,259 | $376,656 | $657,271 | $701,772 |
| Revenue Growth? | +10301.1% | -91.4% | -58.3% | +343.0% | -60.6% | -49.0% | -36.2% | -42.7% | -6.3% | 0.0% |
| Cost of Revenue? | $105,861 | $1,667 | $35,986 | $15,279 | $5,881 | $95,948 | $81,670 | $170,953 | $323,608 | $175,430 |
| Gross Profit? | $691,383 | $5,998 | $53,174 | $198,562 | $42,391 | $26,673 | $158,589 | $205,703 | $333,663 | $526,342 |
| Gross Margin? | +86.7% | +78.3% | +59.6% | +92.9% | +87.8% | +21.8% | +66.0% | +54.6% | +50.8% | +75.0% |
| Operating Expenses? | $5.52M | $5.13M | $3.84M | $3.11M | $4.58M | $3.05M | $4.63M | $4.58M | $3.22M | $2.58M |
| Operating Income? | -$4.83M | -$5.12M | -$3.79M | -$2.91M | -$4.53M | -$3.03M | -$4.47M | -$4.63M | -$2.89M | -$2.18M |
| EBITDA? | -$2.56M | -$3.59M | -$2.68M | -$3.15M | -$4.48M | -$2.83M | -$4.33M | -$4.62M | -$18.52M | -$2.15M |
| Income Before Tax | -$3.51M | -$5.21M | -$3.77M | -$4.38M | -$5.21M | -$3.51M | -$6.05M | -$6.58M | -$29.71M | -$5.90M |
| Income Tax Expense | -$68,617 | $0 | $0 | $0 | $0 | $0 | $0 | $847 | $0 | $0 |
| Net Income? | -$3.44M | -$5.11M | -$3.77M | -$4.37M | -$5.80M | -$4.01M | -$7.71M | -$6.51M | -$29.71M | -$5.90M |
| EPS? | $-0.19 | $-0.49 | $-0.45 | $-0.61 | $-0.89 | $-0.75 | $-2.19 | $-2.60 | $-0.13 | $-0.03 |
| Diluted EPS? | $-0.19 | $-0.49 | $-0.45 | $-0.61 | $-0.89 | $-0.75 | $-2.19 | $-2.60 | $-0.13 | $-0.03 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality